The use of mitotane is unfortunately limited by [[side effect]]s,<ref name="HarrisBouloux2014" /> which, as reported by Schteinberg et al., include [[anorexia (symptom)|anorexia]] and [[nausea]] (88%), [[diarrhea]] (38%), [[vomiting]]  (23%), decreased [[memory]] and ability to concentrate (50%), [[rash]] (23%), [[gynecomastia]] (50%), [[arthralgia]] (19%), and [[leukopenia]] (7%).<ref>{{cite journal|vauthors=Schteinberg DE, Motazedi A, NoonanRA, Thompson NW|title=Treatment of Adrenal Carcinomas|journal=Arch.Surg. | year = 1982 | volume = 117 | pages = 1142â€“1149}}</ref>

 

